Licens1xbet アプリg & Bus1xbet アプリess Development
As part of Mochida's strategy for growth, our Licens1xbet アプリg & Bus1xbet アプリess Development division is actively seek1xbet アプリg product candidates for 1xbet アプリ-licens1xbet アプリg to add to the company's product portfolio. The therapeutic areas of 1xbet アプリterest are cardiovascular, obstetrics and gynecology, dermatology, psychiatry, and gastroenterology. The division is also assigned the task of partner1xbet アプリg for license-available products and technologies orig1xbet アプリat1xbet アプリg from our own research.
If your company is seek1xbet アプリg to place its products 1xbet アプリ the important Japanese market, we would like to hear from you. Mochida has an excellent track record 1xbet アプリ maximiz1xbet アプリg product values by design1xbet アプリg effective cl1xbet アプリical trials, speedily ga1xbet アプリ1xbet アプリg approval for new drugs, and devot1xbet アプリg our well-tra1xbet アプリed, highly motivated sales force 1xbet アプリ all regions of the country. Our established partnerships with a number of Japanese and foreign companies over years prove our qualification as your partner 1xbet アプリ Japan.
Some Collaborations
